Accéder au contenu
Merck
  • Validation of liquid chromatographic method for analysis of lidocaine hydrochloride, dexamethasone acetate, calcium dobesilate, buthylhydroxyanisol and degradation product hydroquinone in suppositories and ointment.

Validation of liquid chromatographic method for analysis of lidocaine hydrochloride, dexamethasone acetate, calcium dobesilate, buthylhydroxyanisol and degradation product hydroquinone in suppositories and ointment.

Journal of chromatography. A (2005-09-01)
Lj Zivanovic, M Zecevic, S Markovic, S Petrovic, I Ivanovic
RÉSUMÉ

In this paper, there was developed a sensitive, precise and accurate reversed-phase liquid chromatographic (RP-HPLC) method and validated for simultaneous determination of lidocaine hydrochloride, dexamethasone acetate (DA) and calcium dobesilate (CD) in suppositories and ointment. Also there was achieved a parallel analysis of buthylhydroxyanisol, as a preservative, and hydroquinone, as a degradation product of calcium dobesilate, present in these dosage forms. The relative standard deviation (RSD) values for all five compounds indicated a good precision and accuracy of the RP-HPLC method. Method is selective, sensitive and reproducible with good recovery values and can be applied in simultaneous determination of all mentioned compounds.

MATÉRIAUX
Référence du produit
Marque
Description du produit

USP
Dexamethasone 21-acetate, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dexamethasone 21-acetate, ≥99%
Dexamethasone 21-acetate, European Pharmacopoeia (EP) Reference Standard